Loading...

Can-Fite BioPharma Ltd.

CANF•AMEX
Healthcare
Biotechnology
$2.91
$-0.05(-1.69%)
U.S. Market opens in 2h 9m

Can-Fite BioPharma Ltd. (CANF) Stock Overview

Explore Can-Fite BioPharma Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.6M
P/E Ratio-4.88
EPS (TTM)$-10.75
ROE-1.41%
Fundamental Analysis

AI Price Forecasts

1 Month$4.51
3 Months$4.44
1 Year Target$0.77

CANF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Can-Fite BioPharma Ltd. (CANF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.88 and a market capitalization of 1.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-4.52%
1-Month Change
-8.64%
3-Month Change
-33.78%
6-Month Change
-69.17%
Year-to-Date (YTD) Change
-26.00%
1-Year Change
-87.46%
3-Year Change
-91.29%
5-Year Change
-99.33%
All-Time (Max) Change
-99.98%

Contact Information

https://www.canfite.com
972 3 924 1114
10 Bareket Street, Petah Tikva, NaN, 4951778

Company Facts

5 Employees
IPO DateNov 6, 2012
CountryIL
Actively Trading

Frequently Asked Questions